Prognostic value of plasma B-type natriuretic peptide levels after exercise in patients with severe asymptomatic aortic stenosis

Heart

Volumn 100, Issue 20, 2014, Pages 1606-1612

  Capoulade, Romain ^a   Magne, Julien ^b   Dulgheru, Raluca ^b   Hachicha, Zeineb ^a   Dumesnil, Jean G ^a   O'Connor, Kim ^a   Arsenault, Marie ^a   Bergeron, Sébastien ^a   Pierard, Luc A ^b   Lancellotti, Patrizio ^b   Pibarot, Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; AORTA VALVE STENOSIS; ASYMPTOMATIC DISEASE; BLOOD; EXERCISE TEST; FEMALE; HUMAN; MALE; PROGNOSIS; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

AGED; AORTIC VALVE STENOSIS; ASYMPTOMATIC DISEASES; EXERCISE TEST; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84922481628     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-305729     Document Type: Article

References (26)

1. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
2. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J AmColl Cardiol 2014;63:2438-88.
3. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-70.
4. Malouf J, Le TT, Pellikka P, et al. Aortic valve stenosis in community medical practice: determinants of outcome and implications for aortic valve replacement. J Thorac Cardiovasc Surg 2012;144:1421-7.
5. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-17.
6. Kang DH, Park SJ, Rim JH, et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010;121:1502-9.
7. Carabello BA. Aortic valve replacement should be operated on before symptom onset. Circulation 2012;126:112-17.
8. Shah PK. Severe aortic stenosis should not be operated on before symptom onset. Circulation 2012;126:118-25.
9. Picano E, Pibarot P, Lancellotti P, et al. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardio 2009;54:2251-60.
10. Lancellotti P, Lebois F, Simon M, et al. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005;112:I377-82.
11. Maréchaux S, Hachicha Z, Bellouin A, et al. Usefulness of exercise stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J 2010;31:1390-7.
12. Lancellotti P, Magne J, Donal E, et al. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation 2012;126:851-9.
13. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004;109:2302-8.
14. Lim P, Monin JL, Monchi M, et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 2004;25:2048-53.
15. Lancellotti P, Moonen M, Magne J, et al. Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis. Am J Cardiol 2010;105:383-8.
16. Foote RS, Pearlman JD, Siegel AH, et al. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 2004; 44:1980-7.
17. Bergeron S, Moller JE, Bailey KR, et al. Exertional changes in circulating cardiac natriuretic peptides in patients with suggested coronary artery disease. J Am Soc Echocardiogr 2006;19:772-6.
18. Kato M, Kinugawa T, Ogino K, et al. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure. J Intern Med 2000;248:309-15.
19. Magne J, Mahjoub H, Pibarot P, et al. Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation. Eur J Heart Fail 2012;14:1293-302.
20. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
21. Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol 2009;54:1003-11.
22. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72.
23. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.
24. Steadman CD, Ray S, Ng LL, et al. Natriuretic peptides in common valvular heart disease. J Am Coll Cardiol 2010;55:2034-48.
25. Gerber IL, Stewart RA, Legget ME, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003;107:1884-90.
26. Huang WS, Lee MS, Perng HW, et al. Circulating brain natriuretic peptide values in healthy men before and after exercise. Metabolism 2002;51:1423-6.